An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review
- PMID: 23808618
- DOI: 10.3109/13651501.2013.813555
An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review
Abstract
Objective: Silexan is a lavender oil preparation in gelatine capsules containing 80 mg. We reviewed the clinical trials investigating the anxiolytic efficacy and tolerability of Silexan as well as its safety and potential for drug interactions.
Methods: Seven trials were included, among which four therapeutic trials had a treatment duration of 6 or 10 weeks.
Results: In patients with subsyndromal anxiety or generalised anxiety disorder (GAD) an anxiolytic effect of Silexan was evident after 2 weeks. Patients treated with Silexan showed Hamilton Anxiety Scale (HAMA) total score decreases between 10.4 ± 7.1 and 12.0 ± 7.2 points at Week 6 and between 11.8 ± 7.7 and 16.0 ± 8.3 points at Week 10.
Conclusions: HAMA total score reductions between baseline and end of treatment were significantly superior to placebo in patients with subsyndromal anxiety and comparable to lorazepam in its starting dose in patients with GAD. Silexan had beneficial effects on typical co-morbidity symptoms of anxiety disorders, for example, disturbed sleep, somatic complaints, or decreased quality of life. Except for mild gastrointestinal symptoms, the drug was devoid of adverse effects and did not cause drug interactions or withdrawal symptoms at daily doses of 80 or 160 mg.
Similar articles
-
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial.Int Clin Psychopharmacol. 2010 Sep;25(5):277-87. doi: 10.1097/YIC.0b013e32833b3242. Int Clin Psychopharmacol. 2010. PMID: 20512042 Clinical Trial.
-
A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.Phytomedicine. 2010 Feb;17(2):94-9. doi: 10.1016/j.phymed.2009.10.006. Epub 2009 Dec 3. Phytomedicine. 2010. PMID: 19962288 Clinical Trial.
-
Silexan in anxiety disorders: Clinical data and pharmacological background.World J Biol Psychiatry. 2018 Sep;19(6):412-420. doi: 10.1080/15622975.2017.1331046. Epub 2017 Jun 19. World J Biol Psychiatry. 2018. PMID: 28511598 Review.
-
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials.Wien Med Wochenschr. 2010 Dec;160(21-22):547-56. doi: 10.1007/s10354-010-0845-7. Wien Med Wochenschr. 2010. PMID: 21170695 Review.
-
Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep--A randomized, placebo-controlled trial.Eur Neuropsychopharmacol. 2015 Nov;25(11):1960-7. doi: 10.1016/j.euroneuro.2015.07.024. Epub 2015 Aug 7. Eur Neuropsychopharmacol. 2015. PMID: 26293583 Clinical Trial.
Cited by
-
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial.Eur Arch Psychiatry Clin Neurosci. 2024 Apr 1. doi: 10.1007/s00406-024-01783-2. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 38558147
-
Plants and mental disorders: the case of Catalan linguistic area.Front Pharmacol. 2023 Oct 31;14:1256225. doi: 10.3389/fphar.2023.1256225. eCollection 2023. Front Pharmacol. 2023. PMID: 38026937 Free PMC article.
-
Development of a Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for Characterizing Linalool Oral Pharmacokinetics in Humans.Molecules. 2023 Sep 6;28(18):6457. doi: 10.3390/molecules28186457. Molecules. 2023. PMID: 37764231 Free PMC article.
-
ACE2 and LOX Enzyme Inhibitions of Different Lavender Essential Oils and Major Components Linalool and Camphor.ACS Omega. 2022 Oct 5;7(41):36561-36566. doi: 10.1021/acsomega.2c04518. eCollection 2022 Oct 18. ACS Omega. 2022. PMID: 36278093 Free PMC article.
-
Plant and fungi derived analgesic natural products targeting voltage-gated sodium and calcium channels.Channels (Austin). 2022 Dec;16(1):198-215. doi: 10.1080/19336950.2022.2103234. Channels (Austin). 2022. PMID: 36017978 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical